Dr. Kathryn (Kate) Martin is the President of Glenmere Research, a consulting firm located in Montebello, NY, that has been providing regulatory and medical editorial services to the pharmaceutical industry for more than 25 years. After receiving her BS from Northeastern University and PharmD from the University of Texas Health Science Center in San Antonio, Kate was the Director of Oncology Pharmacy Services for the Albert Einstein Cancer Center in the Bronx, NY. Her experience in the industry began at Lederle Laboratories in Pearl River, NY, in Medical Affairs and the Medical Research Division. Since founding Glenmere Research in 1995, Dr. Martin has provided regulatory and medical editorial services to large pharma and has assisted numerous small to mid-size companies with US, European, China, and Japan submissions. She has experience writing regulatory documents across the full product lifespan and is familiar with ICH guidelines, standardized templates, and electronic document management systems. Dr. Martin has written manuscripts that have been published in top tier journals including New England Journal of Medicine, Vaccine, Blood, and Contraception, as well as abstracts and posters at numerous domestic and international congresses including ASCO, ESMO, ACC, SABCS, and ASH. She has written content and developed internal medical education slide decks on topics including pathophysiology, therapeutic management, nonclinical and clinical data summaries, and competitive analysis. Her training and primary area of expertise is in oncology/hematology, including transplant and CAR-T therapy, and immunology.